河北中医
河北中醫
하북중의
HEBEI JORNAL OF TRADITIONAL CHINESE MEDICINE
2014年
8期
1147-1148,1202
,共3页
刘秀艳%刘俊敏%程国静%刘宏
劉秀豔%劉俊敏%程國靜%劉宏
류수염%류준민%정국정%류굉
支气管炎,慢性%中药疗法%止咳平喘
支氣管炎,慢性%中藥療法%止咳平喘
지기관염,만성%중약요법%지해평천
Acute tracheo-bronchitis%Chronic%Traditional Chinese medicine therapy%Relieving cough and asthma
目的:观察止咳平喘方治疗慢性支气管炎急性发作期的临床疗效。方法将240例慢性支气管炎急性发作期患者随机分为2组,对照组120例予西医常规治疗,治疗组120例在对照组治疗基础上加止咳平喘方治疗。治疗10 d后观察2组治疗前后肺功能指标第1 s用力呼气容积占预计值百分比( FEV1%)和FEV1/用力肺活量( FVC),并观察治疗前后咳嗽、咯痰、喘息等临床症状变化以评价临床疗效。结果治疗组总有效率93.33%,对照组总有效率82.50%,2组总有效率比较差异有统计学意义(P<0.05),治疗组临床疗效优于对照组。治疗组治疗后肺功能指标FEV1%及FEV1/FVC与本组治疗前及对照组治疗后比较均明显提高(P<0.05)。结论止咳平喘方治疗慢性支气管炎急性发作期,肺功能改善明显,疗效确切,患者耐受良好,安全性高。
目的:觀察止咳平喘方治療慢性支氣管炎急性髮作期的臨床療效。方法將240例慢性支氣管炎急性髮作期患者隨機分為2組,對照組120例予西醫常規治療,治療組120例在對照組治療基礎上加止咳平喘方治療。治療10 d後觀察2組治療前後肺功能指標第1 s用力呼氣容積佔預計值百分比( FEV1%)和FEV1/用力肺活量( FVC),併觀察治療前後咳嗽、咯痰、喘息等臨床癥狀變化以評價臨床療效。結果治療組總有效率93.33%,對照組總有效率82.50%,2組總有效率比較差異有統計學意義(P<0.05),治療組臨床療效優于對照組。治療組治療後肺功能指標FEV1%及FEV1/FVC與本組治療前及對照組治療後比較均明顯提高(P<0.05)。結論止咳平喘方治療慢性支氣管炎急性髮作期,肺功能改善明顯,療效確切,患者耐受良好,安全性高。
목적:관찰지해평천방치료만성지기관염급성발작기적림상료효。방법장240례만성지기관염급성발작기환자수궤분위2조,대조조120례여서의상규치료,치료조120례재대조조치료기출상가지해평천방치료。치료10 d후관찰2조치료전후폐공능지표제1 s용력호기용적점예계치백분비( FEV1%)화FEV1/용력폐활량( FVC),병관찰치료전후해수、각담、천식등림상증상변화이평개림상료효。결과치료조총유효솔93.33%,대조조총유효솔82.50%,2조총유효솔비교차이유통계학의의(P<0.05),치료조림상료효우우대조조。치료조치료후폐공능지표FEV1%급FEV1/FVC여본조치료전급대조조치료후비교균명현제고(P<0.05)。결론지해평천방치료만성지기관염급성발작기,폐공능개선명현,료효학절,환자내수량호,안전성고。
Objective To observe the clinical effect of acute attack stage of chronic bronchitis treated by Zhikepingchuan prescription .Methods 240 patients with acute attack stage of chronic bronchitis were randomly di-vided into control group ,which was treated by routine therapy and treatment group ,which was treated by Zhikeping-chuan prescription on the basis of control group treatment .Pulmonary function indicatrix ( FEV1% and FEV1/FVC) were observed after 10 days of treatment.The changes of clinical symptoms such as cough ,sputum,breathing before and after treatment were observed and clinical effect was evaluated .Results The total effective rate in treatment group (93.33%)was higher than that in control group (82.50%,P<0.05).FEV1% and FEV1/FVC in treatment group were increased as compared with those in control group after treatment ( P<0 .05 ) .Conclusion Zhikeping-chuan prescription on the treatment of acute attack stage of chronic bronchitis can significantly improve patients with lung function,definite curative effect,well tolerated,and high safety.